Caprelsa Interactions
There are 317 drugs known to interact with Caprelsa (vandetanib), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 205 are major, 102 are moderate, and 10 are minor.
- View all 317 medications that may interact with Caprelsa
- View Caprelsa alcohol/food interactions (1)
- View Caprelsa disease interactions (10)
Most frequently checked interactions
View interaction reports for Caprelsa (vandetanib) and the medicines listed below.
- Actemra (tocilizumab)
- Aranesp (darbepoetin alfa)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Brineura (cerliponase alfa)
- Cerdelga (eliglustat)
- Cosentyx (secukinumab)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Entyvio (vedolizumab)
- Epclusa (sofosbuvir / velpatasvir)
- Erivedge (vismodegib)
- Esbriet (pirfenidone)
- Gleevec (imatinib)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Letairis (ambrisentan)
- Nulojix (belatacept)
- Nydrazid (isoniazid)
- Ofev (nintedanib)
- Opsumit (macitentan)
- Pomalyst (pomalidomide)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Rapamune (sirolimus)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
Caprelsa alcohol/food interactions
There is 1 alcohol/food interaction with Caprelsa (vandetanib).
Caprelsa disease interactions
There are 10 disease interactions with Caprelsa (vandetanib) which include:
- QT prolongation
- lung toxicity
- heart failure
- hemorrhage
- hepatic impairment
- hypertension
- hypothyroidism
- ischemic attack
- renal impairment
- RPL syndrome
Report options
QR code containing a link to this page
More about Caprelsa (vandetanib)
- Caprelsa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
